Novel Oral Ketamine Drug Shows Antidepressant Effects Without Dissociative Side Effects in Early Trials
A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.
Read the full articleYou might also wanna read
An Oral Ketamine Drug for Depression — Minus the Trip?
A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects. Medscape Medical News
Oral and Sublingual Ketamine
Conditions : Major Depression Severe Interventions : Drug: 75 mg of oral ketamine; Drug: Sublingual ketamine 75 mg Sponsors : Western Univer
CME | Psychedelics and Mental Health - A New Frontier for Medicine?
In this episode of CME on the Go, host Dr. Lauren Brown-Berchtold, MD, FAAFP, engages in a detailed discussion with Dr. Robert Grant, a pulm
Biomarker-Guided Antidepressant Selection
Conditions : Depression - Major Depressive Disorder; Treatment-resistant Depression (TRD); rTMS; Ketamine; fMRI Interventions : Device: TMS;
Study identifies mu-opioid receptors in prefrontal interneurons as key to ketamine's rapid antidepressant effects
Uncovering ketamine’s rapid antidepressant effects via somatostatin-expressing interneurons in the prefrontal cortex enables the identificat
Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials
Regulators are now mulling the results of the late-stage trial
economist.com·4mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.